TREA

Vibratory nerve exciter

Follow

Information

  • Patent Grant
  • 11229576
  • Patent Number
    11,229,576
  • Date Filed
    Friday, July 2, 2021
    3 years ago
  • Date Issued
    Tuesday, January 25, 2022
    2 years ago
Information
Abstract
A laryngeal nerve exciting system includes a collar holding a bridge, or a neckband, pressing soft tissue nerve exciters against a patient's neck providing a source of vibrations to stimulate the laryngeal nerve through the larynx. At least one exciter, and preferably two exciters, provide vibrations at preferably 70 Hz to 110 Hz and sufficiently strong to penetrate to the laryngeal nerve. The exciters may be held by the collar circling the neck, or by the neck band partially circling the neck. The therapy system includes a Personal Digital Assistant (PDA) and software which wirelessly connects, monitors, and triggers the device. The system may be used to treat dysphagia, chronic cough, and spasmodic dysphonia.
Description
BACKGROUND

The present invention relates to human tissue stimulation and in particular to noninvasive vibration on the neck overlying the larynx to excite the laryngeal nerve to augment or reestablish swallowing control during rehabilitation of patients with dysphagia, and to treat voice disorders affecting the function of the laryngeal system, such as spasmodic dysphonia, and to treat chronic cough.


Dysphagia is a major swallowing disorder that effects the central nervous system, and the peripheral nervous system, thereby weakening neuromuscular control and effectively reducing the ability to properly swallow. Dysphagia may occur at any time across the lifespan. This impairment has many potential causes, including but not limited to neurologic disorders, degenerative disease processes, and anatomical changes. Dysphagia is characterized by difficulty swallowing, impaired ability to protect the airway during swallowing (penetration and aspiration), and impaired ability to transport a bolus of food or liquid from the mouth to the stomach. These difficulties may contribute to a risk for respiratory complications (pneumonia), dehydration, malnutrition, and may restrict social eating. Because of these negative impacts, it also may significantly impact quality of life for an individual.


An occasional cough is normal in that it helps to clear irritants and secretions from the lungs; however, when a cough lasts longer than eight weeks in adults and begins to interfere with daily functions, such as sleep and bladder control, then it may be diagnosed as a chronic cough. In children, this diagnosis may occur after four weeks of coughing. Chronic cough occurs in the upper airway of the respiratory system, and the condition may be caused by co-morbidities, such as asthma, post-nasal drip, or reflux. However, the mechanism is unknown. The cough reflex may be impaired by a disease condition that weakens the cough which could lead to muscle weakness or paralysis, or it may be secondary to laryngeal nerve involvement.


Spasmodic dysphonia is a disorder that may occur with neurological disorders or disease processes that impact laryngeal function and muscles of the voice. This disorder of the laryngeal system causes the muscles involved in voicing to periodically spasm, triggering increased tension and a distortion of the voice. The spasms cause interruptions and breaks in the voice. Causes of spasmodic dysphonia are unknown but may relate to such processes as anxiety, infection, or direct injury to the larynx. It is more common in women and occurs most often between the ages of 30-50 years.


Any neurologic disease or process that impacts laryngeal function may negatively impact swallowing, voicing, and airway functions such as cough and throat clear, or any function that originates within or requires function of the laryngeal system. Various functions within the laryngeal system occur due to stimulation of the afferent pathways which transmit impulses to the brain and are then interpreted for communication with the efferent system for movement. Current treatment for an impairment or changes of laryngeal function that is caused by various neurological disorders or laryngeal injury are typically long-term behavioral therapy or invasive treatment with the injection of foreign materials or medications into the muscles, nerves, or tissues of the larynx. However, various disorders, such as dysphagia, chronic cough, and voicing disorders, may be improved by innervation of the afferent system within the larynx including the branches of the vagus nerve, such as the recurrent laryngeal, superior laryngeal, and pharyngeal branches, and vibration is known to relax muscles and to provide stimulation to tissues being innervated offering an alternative treatment.


U.S. Pat. No. 8,388,561 describes a vibrotactile stimulator having a band 101 worn around a patient's neck and including a vibrator 102 positionable over the larynx to provide stimulation generally centered on the patient's neck. The vibrator 102 is an electric motor spinning an offset weight. While the '561 patent provides a potential method for addressing dysphagia, there remains a need for improved dysphagia therapy devices.


SUMMARY

The present invention addresses the above and other needs by providing a vibrating laryngeal nerve exciting device which includes a collar holding a bridge, or a neckband, pressing soft tissue nerve exciters against a patient's neck providing a source of vibrations to stimulate the branches of the vagus nerve, such as the recurrent laryngeal, superior laryngeal, and pharyngeal branches. At least one exciter, and preferably two exciters, provide vibrations preferably adjustable between 30 Hz and 200 Hz and more preferably between 70 and 110 Hz and sufficiently strong to penetrate to the laryngeal nerve, for example, a pressure of 2-4 kpa or a vibration amplitude of 0.15 mm to 0.25 mm. The exciters may be held by the collar circling the neck, or by the neck band partially circling the neck. The therapy system includes a Personal Digital Assistant (PDA) device and software which wirelessly connects, monitors, and triggers the device. The system may be used to treat dysphagia, chronic cough, and spasmodic dysphonia.


In accordance with one aspect of the invention, there is provided software (e.g., a smartphone application) which wirelessly connects and triggers the device, for example, through a Bluetooth® protocol. The software sets the frequency of the device, intensity, therapy time, vibration time, duration of rest period between vibration, and allows for patients to provide feedback about the therapy. A general state of health section allows the patient to diary how the patient is feeling before and after the therapy. The software allows clinicians to monitor the patient's progress. The clinician can see the device settings (frequency of the device, intensity, therapy time, vibration time, duration of rest period between vibration), number of uses, whether therapy was completed, and the patient's feedback diary.





BRIEF DESCRIPTION OF THE DRAWINGS

The above and other aspects, features and advantages of the present invention will be more apparent from the following more particular description thereof, presented in conjunction with the following drawings.



FIG. 1A shows a front view of a laryngeal nerve exciter according to the present invention.



FIG. 1B shows a top view of the laryngeal nerve exciter according to the present invention.



FIG. 1C shows a rear view of the laryngeal nerve exciter according to the present invention.



FIG. 2 shows an end effector of the laryngeal nerve exciter according to the present invention.



FIG. 3 shows a top view of a second embodiment of a laryngeal nerve exciter according to the present invention.



FIG. 4 shows a neckband laryngeal nerve exciter according to the present invention on a patent.



FIG. 5 shows a top view of the neckband laryngeal nerve exciter according to the present invention.



FIG. 6 shows a perspective view of the neckband laryngeal nerve exciter according to the present invention.



FIG. 7 shows a nerve exciter of the neckband laryngeal nerve exciter according to the present invention.



FIG. 8 shows an adhesive pad of the neckband laryngeal nerve exciter according to the present invention.



FIG. 9 shows a laryngeal nerve exciting system according to the present invention.





Corresponding reference characters indicate corresponding components throughout the several views of the drawings.


DETAILED DESCRIPTION

The following description is of the best mode presently contemplated for carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of describing one or more preferred embodiments of the invention. The scope of the invention should be determined with reference to the claims.


Where the terms “about” or “generally” are associated with an element of the invention, it is intended to describe a feature's appearance to the human eye or human perception, and not a precise measurement.


A front view of a laryngeal nerve exciter 10 according to the present invention is shown in FIG. 1a, a top view of the laryngeal nerve exciter 10 is shown in FIG. 1B, and a rear view of the laryngeal nerve exciter 10 is shown in FIG. 1C. The laryngeal nerve exciter 10 includes a bridge 12, an exciter 14, effector sleeves 16, end effectors 18, strap slots 20, and a strap 22. The exciter 14 is preferably a solenoid or a voice coil, or any device capable of generating vibrations at various frequencies, for example, vibrations between 30 and 200 Hz and preferably between 70 and 110 HZ and sufficiently strong to reach the laryngeal nerve for example, a pressure of 2-4 kpa or a vibration amplitude of 0.15 mm to 0.25 mm.


The end effector 18 of the laryngeal nerve exciter 10 is shown in FIG. 2. A force sensor 24 resides under each end effector 18 and provides force information to allow adjusting the tightness of the strap 22.


A top view of a second embodiment of a laryngeal nerve exciter 30 is shown in FIG. 3. The laryngeal nerve exciter 30 includes end effectors 18a held inside sleeves 16a and springs (or a resilient material) 34 holding the end effectors 18a against transducers 32. An adjust screw 36 presses the transducer 32 and end effector 18a against the spring 34 allowing adjustment of the end effectors 18a against the patient's neck without adjusting the strap 22. The transducers 32 may both vibrate the end effectors 18a to stimulate the laryngeal nerve and may sense a patient's attempt to swallow, and may sense stimulation by the other end effector 18a. The laryngeal nerve exciter 30 may include the force sensor 24 under the effector 16a. In another embodiment, the end effectors 18a may be fixedly attached to the moving part of the transducers 32 and no spring 34 is required.



FIG. 4 shows a neckband laryngeal nerve exciter (neckband trainer) 42 on a patient 40. The neckband trainer 42 does not press against the patient's throat providing greater comfort for the patient. Two exciters 44 are pressed against sides of the neck. The exciters 44 preferably receive up to 10 Watts (five Watts per exciter). The neckband trainer 42 provides pressure to the area where the exciters 44 contact the neck. The force of the exciters 44 against the neck is measured and an alarm is generated if the force exceeds a threshold.



FIG. 5 shows a top view of the neckband trainer 42 and FIG. 6 shows a perspective view of the neckband trainer 42. The neckband trainer 42 includes the exciters 44, a circuit 46, and battery compartments 48 and 50. The neckband trainer 42 includes a charging port for charging batteries and is adjustable for individual patients.



FIG. 7 shows a nerve exciter 44 of the neckband laryngeal nerve exciter.



FIG. 8 shows an adhesive pad 52 of the neckband trainer 42. The adhesive pad 52 comprises a top adhesive pad 54, a plastic snap 56, and a bottom adhesive pad 58. The exciter 44 snaps onto the adhesive pad 52 to retain the exciter 44 against the patient's neck.


A laryngeal nerve exciter system 60 is shown in FIG. 9. The system 60 utilizes a software Application (App) residing in a Personal Digital Assistant (PDA) 64 which triggers, and monitors the neckband trainer 42 through a Bluetooth® interface 62. The interface 62 may include frequency, intensity, therapy time, vibration time, duration of rest period between vibration, and allows for patients to provide feedback about the therapy.


The PDA 64 may communicate with a secure server 68 through the Internet or any other suitable connection including wireless or wired connections 66 providing signals include frequency, intensity, therapy time, vibration time, duration of rest period between vibration, clinician calibration, and allows for patients to provide feedback about the therapy.


The secure server 68 may communicate with a work station 72 over the Internet or any other suitable connection including wireless or wired connections 70 providing signals include frequency, intensity, therapy time, vibration time, duration of rest period between vibration, and clinician calibration, and allows for patients to provide feedback about the therapy to the clinician.


The App may set the frequency of the neckband trainer 42, intensity, therapy time, vibration time, duration of rest period between vibration, and allows for patients to provide feedback about the therapy. Measurements made by the neckband trainer 42 (e.g., force measured by the exciters) may be provided to the PDA 46 via the Bluetooth® connection. Further, the system 60 may allow clinicians to monitor the patient's progress. The clinician will be able to see the device settings, frequency of the device, intensity, therapy time, vibration time, duration of rest period between vibration, number of uses, whether therapy was completed, and the patient feedback. A general state of health section for the patient may be provided to indicate how the patient is feeling before and after the therapy. The PDA 64 may be a smart phone.


While the invention herein disclosed has been described by means of specific embodiments and applications thereof, numerous modifications and variations could be made thereto by those skilled in the art without departing from the scope of the invention set forth in the claims.

Claims
  • 1. A laryngeal nerve exciter system, comprising: a neckband configured to wrap at least partially around a neck of a patient, the neckband comprising a first circumferential end and a second circumferential end opposing each other;a bridge comprising a middle portion, a first side portion and a second side portion, the first side portion and the second side portion respectively extending from opposing ends of the middle portion to form an obtuse angle with respect to the middle portion, the first side portion coupled to the first circumferential end of the neckband, the second side portion coupled to the second circumferential end of the neckband, each of the middle portion, and the first side portion and the second side portion comprising a first surface configured to face the patient's neck and a second surface opposing the first surface;a first sleeve extending from the first surface of the first side portion of the bridge, the first sleeve including a first opening;a second sleeve extending from the first surface of the second side portion of the bridge, the second sleeve including a second opening;an exciter configured to generate vibration, wherein the exciter comprises a single exciter disposed on the second surface of the middle portion of the bridge, the first nerve effector and the second nerve effector arranged substantially symmetric with respect to the single exciter;a first nerve effector operatively coupled to the exciter and configured to conduct the vibration to the patient's neck to stimulate a laryngeal nerve of the patient, the first nerve effector comprising a first end disposed inside the first opening of the first sleeve and a second end disposed outside the first opening and configured to directly contact a first portion of the patient's neck;a second nerve effector operatively coupled to the exciter and configured to conduct the vibration to the patient's neck to stimulate the laryngeal nerve, the second nerve effector comprising a first end disposed inside the second opening of the second sleeve and a second end disposed outside the second opening and configured to directly contact a second portion of the patient's neck different from the first portion of the patient's neck;a first force sensor disposed inside the first opening of the first sleeve and configured to measure force of the first nerve effector against the first portion of the patient's neck to allow for adjustment of the first circumferential end of the neckband;and a second force sensor disposed inside the second opening of the second sleeve and configured to measure force of the second nerve effector against the second portion of the patient's neck to allow for adjustment of the second circumferential end of the neckband.
  • 2. The laryngeal nerve exciter system of claim 1, wherein the single exciter comprises a voice coil or a solenoid.
  • 3. The laryngeal nerve exciter system of claim 1, wherein each of the first sleeve and the second sleeve comprises a top configured to face the patient's neck and a bottom opposing the top, and wherein the first sleeve and the second sleeve are arranged oblique with respect to each other such that a distance between the bottoms of the first sleeve and the second sleeve is greater than a distance between the tops of the first sleeve and the second sleeves.
  • 4. The laryngeal nerve exciter system of claim 1, wherein the exciter is configured to generate the vibration at a frequency between 30 Hz and 200 Hz, at a pressure of 2 kPa to 4 kPa or at a vibration amplitude of 0.15 mm to 0.25 mm.
  • 5. A laryngeal nerve exciter system, comprising: a neckband configured to wrap at least partially around a patient's neck, the neckband comprising a first end and a second end opposing each other;a bridge comprising a middle portion, a first side portion and a second side portion, the first side portion and the second side portion respectively non-linearly extending from opposing ends of the middle portion, the first side portion coupled to the first end of the neckband, the second side portion coupled to the second end of the neckband, each of the middle portion, and the first and second side portions comprising a first surface configured to face the patient's neck and a second surface opposing the first surface;a first sleeve extending from the first surface of the first side portion of the bridge, the first sleeve including a first opening;a second sleeve extending from the first surface of the second side portion of the bridge, the second sleeve including a second opening;a first nerve effector configured to conduct vibration to the patient's neck to stimulate a laryngeal nerve of the patient, the first nerve effector comprising a first end disposed inside the first opening of the first sleeve and a second end disposed outside the first opening and configured to directly contact a first portion of the patient's neck;a second nerve effector configured to conduct the vibration to the patient's neck to stimulate the laryngeal nerve, the second nerve effector comprising a first end disposed inside the second opening of the second sleeve and a second end disposed outside the second opening and configured to directly contact a second portion of the patient's neck different from the first portion of the patient's neck;an exciter operatively coupled to the first nerve effector and the second nerve effector and configured to generate the vibration, wherein the exciter comprises a first transducer and a second transducer respectively operatively coupled to the first nerve effector and the second nerve effector, the first transducer and the second transducer respectively disposed inside the first opening and the second opening of the first sleeve and the second sleeve, and further comprising a first resilient member accommodated inside the first opening of the first sleeve and configured to hold the first nerve effector against the first transducer; anda second resilient member accommodated inside the second opening of the second sleeve and configured to hold the second nerve effector against the second transducer.
  • 6. The laryngeal nerve exciter system of claim 5, wherein the first nerve effector is directly coupled to the first transducer, and wherein the second nerve effector is directly coupled to the second transducer.
  • 7. The laryngeal nerve exciter system of claim 5, wherein at least one of the first resilient member or the second resilient member comprises a spring, the spring having a first end and a second end opposing each other, the second end of the spring being closer to the first transducer or the second transducer than the first end of the spring, the first end of the spring fixed to an internal portion of the first sleeve or the second sleeve, the second end of the spring configured to elastically move to allow for adjustment of the first nerve effector or the second nerve effector against the patient's neck without adjusting the neckband.
  • 8. The laryngeal nerve exciter system of claim 5, wherein at least one of the first transducer or the second transducer is configured to sense the patient's attempt to swallow.
  • 9. The laryngeal nerve exciter system of claim 5, wherein the first transducer is configured to sense stimulation by the second nerve effector, and wherein the second transducer is configured to sense stimulation by the first nerve effector.
  • 10. The laryngeal nerve exciter system of claim 5, further comprising: a first force sensor disposed inside the first opening of the first sleeve and configured to measure three of the first nerve effector against the first portion of the patient's neck to allow for adjustment of the first end of the neckband; anda second force sensor disposed inside the second opening of the second sleeve and configured to measure force of the second nerve effector against the second portion of the patient's neck to allow for adjustment of the second end of the neckband.
  • 11. The laryngeal nerve exciter system of claim 10, wherein the first force sensor is disposed between the first transducer and the first resilient member, and wherein the second force sensor is disposed between the second transducer and the second resilient member.
  • 12. The laryngeal nerve exciter system of claim 11, wherein the first side portion of the bridge includes a first through-hole, wherein the second side portion of the bridge includes a second through-hole, and wherein each of the first sleeve and the second sleeve comprises a lower portion accommodated in the first through-hole or the second through-hole.
  • 13. The laryngeal nerve exciter system of claim 12, wherein each of the first sleeve and the second sleeve further comprises an upper portion extending from the first surface of the first sleeve or the second sleeve, and wherein the upper portion is longer than the lower portion.
  • 14. The laryngeal nerve exciter system of claim 13, further comprising: a first adjustment screw at least partially accommodated inside the lower portion of the first sleeve, the first adjustment screw configured to move the first transducer and the first nerve effector inside the first sleeve; anda second adjustment screw at least partially accommodated inside the lower portion of the second sleeve, the second adjustment screw configured to move the second transducer and the second nerve effector inside the second sleeve.
  • 15. The laryngeal nerve exciter system of claim 14, wherein each of the first adjustment screw and the second adjustment screw comprises a head portion disposed outside the first sleeve or the second sleeve and a body portion disposed at least partially inside the lower portion of the first sleeve or the second sleeve, the body portion directly contacting the first transducer or the second transducer.
  • 16. The laryngeal nerve exciter system of claim 5, wherein the first sleeve comprises a top configured to face the patient's neck and a bottom opposing the top, and wherein the first sleeve and the second sleeve are arranged oblique with respect to each other such that a distance between the bottoms of the first sleeve and the second sleeve is greater than a distance between the tops of the first sleeve and the second sleeve.
  • 17. A laryngeal nerve exciter system, comprising: a neckband configured to wrap at least partially around a patient's neck, the neckband comprising a first end and a second end opposing each other;a bridge comprising a middle portion, a first side portion and a second side portion, the first side portion and the second side portion respectively extending from opposing ends of the middle portion, the first side portion coupled to the first end of the neckband, the second side portion coupled to the second end of the neckband, each of the middle portion, and the first side portion and the second side portion comprising a first surface configured to face the patient's neck and a second surface opposing the first surface;a first sleeve extending from the first surface of the first side portion of the bridge;a second sleeve extending from the first surface of the second side portion of the bridge;a first nerve effector configured to conduct vibration to the patient's neck to stimulate a laryngeal nerve of the patient, the first nerve effector further configured to directly contact a first portion of the patient's neck;a second nerve effector configured to conduct the vibration to the patient's neck to stimulate the laryngeal nerve, the second nerve effector further configured to directly contact a second portion of the patient's neck different from the first portion of the patient's neck, each of the first nerve effector and the second nerve effector partially disposed inside and movable with respect to the first sleeve or the second sleeve;and an exciter operatively coupled to the first nerve effector and the second nerve effector and configured to generate the vibration, wherein the exciter comprises a first transducer and a second transducer respectively operatively coupled to the first nerve effector and the second nerve effector, the first transducer and the second transducer respectively disposed inside a first opening and a second opening of the first sleeve and the second sleeve, and further comprising a first resilient member accommodated inside the first opening of the first sleeve and configured to hold the first nerve effector against the first transducer;and a second resilient member accommodated inside the second opening of the second sleeve and configured to hold the second nerve effector against the second transducer.
  • 18. The laryngeal nerve exciter system of claim 17, wherein the first side portion and the second side portion of the bridge non-linearly extend from the middle portion of the bridge.
  • 19. The laryngeal nerve exciter system of claim 18, wherein the first side portion and the second side portion of the bridge form an obtuse angle with respect to the middle portion of the bridge.
CROSS-REFERENCE TO RELATED APPLICATIONS

The application is a continuation of U.S. patent application Ser. No. 16/853,477, filed Apr. 20, 2020, which claims the priority of U.S. Provisional Patent Application No. 62/836,195, filed Apr. 19, 2019, the disclosures of each of which is incorporated in its entirety herein by reference.

US Referenced Citations (68)
Number Name Date Kind
4143648 Cohen et al. Mar 1979 A
4685448 Shames et al. Aug 1987 A
5007410 DeLaney Apr 1991 A
5086788 Castel et al. Feb 1992 A
5111814 Goldfarb May 1992 A
5350407 McClure et al. Sep 1994 A
5562718 Palermo Oct 1996 A
5611771 Taylor Mar 1997 A
5725564 Freed et al. Mar 1998 A
5871508 Thompson et al. Feb 1999 A
5891185 Freed et al. Apr 1999 A
5897579 Sanders Apr 1999 A
5987359 Freed et al. Nov 1999 A
6039679 Yu Mar 2000 A
6104958 Freed et al. Aug 2000 A
6131535 So Oct 2000 A
6198970 Freed et al. Mar 2001 B1
6343232 Mower Jan 2002 B1
6354991 Gross et al. Mar 2002 B1
6393323 Sawan et al. May 2002 B1
6484053 Leelamanit et al. Nov 2002 B2
6735315 Ifukube et al. May 2004 B1
7039468 Freed et al. May 2006 B2
7182738 Bonutti et al. Feb 2007 B2
7254444 Moore et al. Aug 2007 B2
7280873 Freed et al. Oct 2007 B2
7349739 Harry et al. Mar 2008 B2
7582066 Shimotori Sep 2009 B2
7606623 Ludlow et al. Oct 2009 B2
7660636 Castel et al. Feb 2010 B2
8388561 Ludlow et al. Mar 2013 B2
8449445 Ludlow et al. May 2013 B2
8579839 Ludlow et al. Nov 2013 B2
8808207 Ludlow et al. Aug 2014 B2
8852074 Ludlow et al. Oct 2014 B2
10071016 Ludlow et al. Sep 2018 B2
20020010495 Freed et al. Jan 2002 A1
20020049479 Pitts Apr 2002 A1
20020133194 Leelamanit et al. Sep 2002 A1
20030093128 Freed et al. May 2003 A1
20040073271 Harry et al. Apr 2004 A1
20040133133 Dreimann et al. Jul 2004 A1
20040249320 Yamazaki et al. Dec 2004 A1
20040267331 Koeneman et al. Dec 2004 A1
20050049453 Faulkner Mar 2005 A1
20050059909 Burgess Mar 2005 A1
20050267388 Hanna Dec 2005 A1
20060030794 Nation et al. Feb 2006 A1
20070073361 Goren et al. Mar 2007 A1
20070293926 Dunlay et al. Dec 2007 A1
20080077192 Harry et al. Mar 2008 A1
20080195006 Stark Aug 2008 A1
20090048645 Philipp et al. Feb 2009 A1
20090054980 Ludlow et al. Feb 2009 A1
20100016908 Martin et al. Jan 2010 A1
20100241191 Testerman et al. Sep 2010 A1
20110125212 Tyler May 2011 A1
20120046579 Radi et al. Feb 2012 A1
20120296243 Ludlow et al. Nov 2012 A1
20130102937 Ehrenreich et al. Apr 2013 A1
20140276270 Ludlow Sep 2014 A1
20170165101 Davidian Jun 2017 A1
20180233225 Experton et al. Aug 2018 A1
20190053968 Vergara Feb 2019 A1
20190151604 Harper et al. May 2019 A1
20190159953 Konczak May 2019 A1
20190262212 Schroeder Aug 2019 A1
20190262225 Gertner et al. Aug 2019 A1
Foreign Referenced Citations (26)
Number Date Country
2006265985 Mar 2011 AU
2011201177 Apr 2011 AU
2614072 Jan 2019 CA
101716394 Jun 2010 CN
0 226 333 Jun 1987 EP
1917067 Jan 2007 EP
2334278 Jun 2011 EP
1117439 Jan 2009 HK
62-174788 Jul 1987 JP
S64-046459 Feb 1989 JP
H06-190017 Jul 1994 JP
H09-084845 Mar 1997 JP
11-500339 Jan 1999 JP
2003-111748 Apr 2003 JP
2006-500994 Jan 2006 JP
2007-151736 Jun 2007 JP
2008-520306 Jun 2008 JP
2008-544832 Dec 2008 JP
WO 9221407 Dec 1992 WO
WO 9715349 May 1997 WO
WO 2004028433 Apr 2004 WO
WO 2006054118 May 2006 WO
WO 2007005582 Jan 2007 WO
WO 2007123746 Nov 2007 WO
WO 2010033594 Mar 2010 WO
WO 2016001393 Jan 2016 WO
Non-Patent Literature Citations (132)
Entry
Office Action dated Sep. 11, 2020 in U.S. Appl. No. 16/853,477, in 16 pages.
Final Office Action dated Mar. 25, 2021 in U.S. Appl. No. 16/853,477, in 34 pages.
Andersen et al., Modulation of heat evoked nociceptive withdrawal reflexes by painful intramuscular conditioning stimulation, Exp Brain Res, 2006, vol. 174, pp. 755-780.
Aviv et al., “Laryngopharyngeal sensory testing with modified barium swallow as predictors of aspiration pneumonia after stroke”, Laryngoscope, 107:1254-1260 (1997).
Aviv et al., “Silent laryngopharyngeal sensory deficits after stroke”, Ann Otol Rhinol. Laryngol., 106:87-93(1997).
Aviv et al., “Supraglottic and pharyngeal sensory abnormalities in stroke patients with dysphagia”, Ann Otol Rhinol.Laryngol., 105:92-97 (1996).
Bara-Jimenez et al., “Abnormal somatosensory homunculus in dystonia of the hand”, Ann Neurol., 44(5):828-831 (1998).
Bara-Jimenez et al., “Sensory discrimination capabilities in patients with focal hand dystonia”, Ann Neural., 47(3):377-380 (2000).
Bhadra et al., Extraction Force and Tissue Change During Removal of a Tined Intramuscular Electrode from Rat Gastrocnemius, Annals of Biomedical Engineering, Jun. 2006, vol. 34, Issue No. 6, pp. 1042-1050.
Bidus et al., “Effects of Adductor Muscle Stimulation on Speech in Abductor Spasmodic Cysphonia”, The Laryngoscope, 110:1943-1949 (2000).
Bielamowicz et al., “Effects of botulinum toxin on pathophysiology in spasmodic dysphonia”, Ann Otol Rhinol Laryngol, 109: 194-203 (2000).
Burnett et al., “Laryngeal elevation achieved by neuromuscular stimulation at rest”, J Appl Physiol, 94(1): 128-134 (2003).
Burnett et al., “Self-Triggered Functional Electrical Stimulation During Swallowing”, J Neurophysiol, 94(6):4011-4018 (2005).
Caetano et al., Evidence of vibrotactile input to human auditory cortex, NeuroImage, 2006, vol. 29, pp. 15-28.
Celichowski et al., The time course of the last contractions during incompletely fused tetani of motor units in rat skeletal muscle, Acta Neurobiol. Exp., 2002, vol. 62, pp. 7-17.
Chou et al., Predicting optimal electrical stimulation for repetitive human muscle activation, Journal of Electromyography and Kinesiology, 2005, vol. 15, pp. 300-309.
Conforto et al., “Increase in hand muscle strength of stroke patients after somatosensory stimulation”, Ann Neurol, 51(1): 122-125 (2002).
Daly et al., “Performance of an intramuscular electrode during functional neuromuscular stimulation for gait training post stroke”, Journal of Rehabilitation Research and Development, 38(5):513-526 (2001).
Davis et al., Quantitative analysis of laryngeal mechanosensitivity in the cat and rabbit, J. Physiol., 1987, vol. 388, pp. 467-485.
De Larminat et al., “Alteration in swallowing reflex after extubation in intensive care unit patients”, Crit Care Med, 23(3):486-490 (1995).
De Nil et al., “Kinaesthetic acuity of stutterers and non-stutterers for oral and non-oral movements”, Brain, 114:2145-2158 (1991).
Decision of Rejection issued in Japanese Patent Application No. 2011 -527935, dated Jan. 21, 2014.
Decision of Rejection issued in Japanese Patent Application No. 2013-025371, dated Oct. 20, 2014.
Dick et al., “Interaction between central pattern generators for breathing and swallowing in the cat”, J Physiol, 465:715-730 (1993).
Experia™: The Next Generation of VitalStim® Therapy brochure, 2007 Encore Medical, L.P. and Affiliates, 2 pages.
Extended European Search Report for European Patent Application No. 11005014.3 dated Sep. 30, 2011.
Final Office Action in Japanese Application No. 2008-520302, dated Aug. 14, 2012.
Final Office Action issued in U.S. Appl. No. 11/993,094, dated Oct. 16, 2012.
Final Office Action issued in U.S. Appl. No. 12/211,633, dated Sep. 17, 2012.
Final Office Action issued in U.S. Appl. No. 12/240,398, dated Jun. 21, 2012.
Final Office Action issued in U.S. Appl. No. 13/492,044, dated Jun. 4, 2013.
First Action Interview Pilot Program Pre-Interview Communication issued in U.S. Appl. No. 13/492,044, dated Oct. 18, 2012.
Final Office Action issued in U.S. Appl. No. 13/777,907, dated Mar. 26, 2014.
Final Office Action issued in U.S. Appl. No. 13/492,044, dated May 2, 2014.
Final Office Action issued in U.S. Appl. No. 13/799,549, dated Jun. 8, 2016.
Final Office Action issued in U.S. Appl. No. 14/471,369, dated Apr. 6, 2017.
Folstein et al., “Mini-mental state. A practical method for grading the cognitive state of patients for the clinician”, J Psychiatr Res, 12(3):189-198 (1975).
Fraser et al., “Differential changes in human pharyngoesophageal motor excitability induced by swallowing, pharyngeal stimulation, and anesthesia”, Am J Physiol Gastrointest Liver Physiol, 285(1):G137-144 (2003).
Freed et al., “Electrical Stimulation for Swallowing Disorders Caused by Stroke”, Respiratory Care, 46(5):466-474 (2001).
Grottel et al., The Influence of changes in the stimulation pattern on force and fusion in motor units of the rat medial gastrocnemius muscle, Exp Brain Res, 1999, vol. 127, pp. 298-306.
Hägg et al., “Effects of motor and sensory stimulation in stroke patients with long-lasting dysphagia”, Dysphagia, 19:219-230 (2004).
Hamdy et al., “Modulation of human swallowing behaviour by thermal and chemical stimulation in health and after brain injury”, Neurogastroenterol Motil, 15(1):69-77 (2003).
Handa et al., “Development of Percutaneous Intramuscular Electrode for Multichannel FES System”, IEEE Transactions on Biomedical Engineering, 36(7):705-710.
Haslinger et al., “Silent event-related fMRI reveals reduced sensorimotor activation in laryngeal dystonia”, Neurology, 65:1562-1569 (2005).
Hrycyshyn et al., “Electromyography of the Oral Stage of Swallowing in Man”, Am. J. Anat., 133:333-340(1972).
Humbert et al., “The effect of surface electrical stimulation on hyolaryngeal movement in normal individuals at rest and during swallowing”, J Appl Physiol, 101:1657-1663 (2006).
Humbert et al., The Effect of Surface Electrical Stimulation on Vocal Fold Posiiton, The Laryngoscope, Jan. 2008, vol. 118, pp. 14-19.
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority for International Application No. PCT/US2006/025535, dated Jan. 9, 2008.
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority for International Application No. PCT/US2007/007993, dated Sep. 30, 2008.
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority for International Application No. PCT/US2009/057158, dated Mar. 22, 2011.
International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2006/025535, dated Nov. 21, 2006.
International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2007/007993, dated Mar. 5, 2008.
International Search Report for International Application No. PCT/US03/30032 dated Apr. 9, 2004.
International Search Report for International Application No. PCT/US2009/057158, dated Mar. 26, 2010.
International Search Report for International Application No. PCT/US2014/014208 dated Jun. 26, 2014.
Jafari et al., “Sensory regulation of swallowing and airway protection: a role for the internal superior laryngeal nerve in humans”, J Physiol, 550(Pt I):287-304 (2003).
Jean, “Control of the central swallowing program by inputs from the peripheral receptors. A review”, J Auton. Ner. Syst., 10:225-233 (1984).
Jean, Brain Stem Control of Swollowing: Neuronal Network and Cellular Mechanisms, Physiological Reviews, Apr. 2001, vol. 81, Issue No. 2, pp. 929-969.
Kamarunas et al., “Vibration overlying the larynx increases swallowing in chronic oropharyngeal dysphagia,” Original Research, pp. 1-41, Jul. 17, 2017.
Kesar et al., Effect of frequency and pulse duration on human muscle fatigue during repetitive electrical stimulation, Exp Physiol, 2006, vol. 91, Issue No. 6, pp. 967-976.
Kimberley et al., “Electrical stimulation driving functional improvements and cortical changes in subjects with stroke”, Experimental Brain Research, 2004, vol. 154, pp. 450-460.
Kitagawa et al., Facilitation of reflex swallowing from the pharynx and larynx, Journal of Oral Science, 2009, vol. 51, Issue No. 2, pp. 167-171.
Knutson et al., Electrode fracture rates and occurrences of infection and granuloma associated with percutaneous intramuscular electrodes in upper-limb functional electrical stimulation applications, Journal of Rehabilitation Research and Development, 2002, vol. 39, Issue No. 6, pp. 671-683.
Leelamanit et al., “Synchronized electrical stimulation in treating pharyngeal dysphagia”, Laryngoscope, 112(12):2204-2210 (2002).
Logemann et al., “Effects of a sour bolus on oropharyngeal swallowing measures in patients with neurogenic dysphagia”, J Speech Hear Res, 38(3):556-563 (1995).
Logemann, “Noninvasive approaches to deglutitive aspiration”, Dysphagia, 8(4):331 -333 (1993).
Loucks et al., “Laryngeal muscle responses to mechanical displacement of the thyroid cartilage in humans”, J Appl Physiol, 99(3):922-930 (2005).
Lowell et al., “Sensory stimulation activates both motor and sensory components of the swallowing system”, NeuroImage, 42:285-295 (2008).
Ludlow et al., “Chronic Intermittent Stimulation of the Thyroarytenoid Muscle Maintains Dynamic Control of Glottal Adduction”, Muscle and Nerve, 23:44-57 (2000).
Ludlow et al., “Dynamic aspects of phonatory control in spasmodic dysphonia”, J Speech Hear Res, 30:197-206(1987).
Ludlow et al., “Effects of Surface Electrical Stimulation Both at Rest and During Swallowing in Chronic Pharyngeal Dysphagia”, Dysphagia, 22:1-10 (2007).
Ludlow et al., “Three-Dimensional Changes in the Upper Airway During Neuromuscular Stimulation of Laryngeal Muscles”, Journal of Artificial Organs, 23:463-465 (1999).
Lundy et al., “Aspiration: Cause and Implications”, Otolaryngol Head Neck Surg., 120(4):474-478 (1999).
Marsolais et al., “Implantation techniques and experience with percutaneous intramuscular electrodes in the lower extremities”, J. Rehabil. Res. Dev., 23(3):1-8 (1986).
Mifflin, “Intensity and frequency dependence of laryngeal afferent inputs to respiratory hypoglossal motoneurons”, J.Appl Physiol, 83:1890-1899 (1997).
Mortimer et al., “Intramuscular Electrical Stimulation: Tissue Damage”, Ann. Biomed. Eng., 8:235-244(1980).
Mortimer et al., Vibrotactile transduction and transducers, J. Acoust. Soc. Am., May 2007, vol. 121, Issue No. 5, pp. 2970-2977.
Mulheren et al., “Vibration over the larynx increases swallowing and cortical activation for swallowing”, J. Neurophysiol., 118: 169-1708, Jul. 5, 2017.
Nishino et al., “Cough and other reflexes on irritation of airway mucosa in man”, Pulm Pharmacol, 9(5-6):285-292 (1996).
Notice of Acceptance issued in Australian Application No. 2011201177, dated Mar. 12, 2013.
Notice of Acceptance issued in Australian Patent Application No. 2006265985 on Dec. 1, 2010.
Notice of Acceptance issued in Australian Patent Application No. 2009293277, dated Feb. 25, 2014.
Notice of Allowance issued in Japanese Application No. 2008-520302, dated Aug. 6, 2013.
Notice of Allowance issued in U.S. Appl. No. 11/993,094, dated Jun. 27, 2013.
Notice of Allowance issued in U.S. Appl. No. 12/211,633, dated Oct. 30, 2012.
Notice of Allowance issued in U.S. Appl. No. 12/240,398, dated Feb. 1, 2013.
Notice of Allowance issued in U.S. Appl. No. 13/777,907, dated Apr. 11, 2014.
Notice of Allowance issued in U.S. Appl. No. 13/902,263, dated Jun. 6, 2014.
Notice of Panel Decision from Pre-Appeal Brief Review issued in U.S. Appl. No. 13/492,044, dated Nov. 15, 2013.
Office Action in Australian Patent Application No. 2011201177, dated Aug. 1, 2012.
Office Action issued in Australian Patent Application No. 2006265985 on Oct. 20, 2009.
Office Action issued in Australian Patent Application No. 2011201177, dated Feb. 23, 2012.
Office Action issued in EP Application No. 11 005 014.3, dated Jun. 8, 2012.
Office Action issued in European Patent Application No. 06785933.0 on Feb. 10, 2011.
Office Action issued in Japanese Application No. 2011-527935, dated Jan. 15, 2013.
Office Action issued in Japanese Application No. 2011-527935, dated Jul. 16, 2013.
Office Action issued in Japanese Patent Application No. 2008-520302 on Nov. 15, 2011.
Office Action issued in Japanese Patent Application No. 2013-025371, dated Feb. 10, 2014.
Office Action issued in U.S. Appl. No. 11/993,094, dated Feb. 4, 2013.
Office Action issued in U.S. Appl. No. 13/492,044, dated Dec. 4, 2013.
Office Action issued in Canadian Patent Application No. 2,737,478, dated Sep. 30, 2016.
Office Action issued in Canadian Patent Application No. 2,614,072, dated Jan. 26, 2016.
Office Action issued in U.S. Appl. No. 17/305,280, dated Sep. 28, 2021.
Office Action issued in U.S. Appl. No. 17/305,282, dated Sep. 14, 2021.
Ootani et al., “Convergence of afferents from the SLN and GPN in cat medullary swallowing neurons”, Brain Res Bull, 37(4):397-404 (1995).
Park et al., “A pilot exploratory study of oral electrical stimulation on swallow function following stroke: an innovative technique”, Dysphagia, 12(3):161-166 (1997).
Patent Examination Report issued in Australian Application No. AU2009293277, dated Jun. 7, 2013.
Pertovaara, Modification of human pain threshold by specific tactile receptors, Acta Physiol Scand, 1979, vol. 107, pp. 339-341.
Peurala et al., “Cutaneous electrical stimulation may enhance sensorimotor recovery in chronic stroke”, Clin Rehabil., 16:709-716 (2002).
Pick et al., “Pulmonary aspiration in a long-term care setting: clinical and laboratory observations and an analysis of risk factors”, J Am Geriatr Soc, 44(7):763-768 (1996).
Pommerenke, “A study of the sensory areas eliciting the swallowing reflex”, American Journal of Physiology, 84(1):36-41 (1927).
Portone et al., “A review of patient adherence to the recommendations for voice therapy”, J. Voice, 22:192-196 (2008).
Power et al., “Changes in pharyngeal corticobulbar excitability and swallowing behavior after oral stimulation”, Am J Physiol Gastrointest Liver Physiol, 286(1):G45-50 (2004).
Power et al., “Evaluating oral stimulation as a treatment for Dysphagia after stroke”, Dysphagia, 21(1):49-55 (2006).
Restriction Requirement issued in U.S. Appl. No. 13/902,263, dated Oct. 11, 2013.
Restriction Requirement issued in U.S. Appl. No. 11/993,094 on Jan. 24, 2012.
Restriction Requirement issued in U.S. Appl. No. 12/240,398 on Nov. 23, 2011.
Robbins et al., “Swallowing and dysphagia rehabilitation: translating principles of neural plasticity into clinically orientated evidence”, J Speech Lang. Hear. Res., 51:S276-300 (2008).
Scheiner et al., “Design and Clinical Application of a Double Helix Electrode for Functional Electrical Stimulation”, IEEE Transactions of Biomedical Engineering, 41 (5):425-431 (1994).
Sedory-Holzer et al., “The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia”, Laryngoscope, 106:86-92 (1996).
Setzen et al., “The association between laryngopharyngeal sensory deficits, pharyngeal motor function, and the prevalence of aspiration with thin liquids”, Otolaryngol Head Neck Surg, 128(1):99-102 (2003).
Spiro et al., “Activation and Coordination Patterns of the Suprahyoid Muscles During Swallowing”, Laryngoscope, 104:1376-1382 (1994).
Stanic et al., “Multichannel Electrical Stimulation for Correction of Hemiplegic Gait”, Scand J. Rehabil. Med., 10:75-92 (1978).
Strojnik et al., “Treatment of Drop Foot Using an Implantable Peroneal Underknee Stimulator”, Scand J. Rehabil. Med., 19:37-43 (1987).
Struppler et al., “Modulation of sensorimotor performances and cognition abilities induced by RPMS: clinical and experimental investigations”, Suppl Clin Neurophysiol., 56:358-367 (2003).
Sundgren et al., “Elevation of the larynx on normal and abnormal cineradiogram”, The British Journal of Radiology, 66:768-772(1993).
Supplementary European Search Report for European Application No. 03776191.3 dated May 14, 2008.
Theurer et al., “Oropharyngeal stimulation with air-pulse trains increases swallowing frequency in healthy adults”, Dysphagia, 20(4):254-260 (2005).
Van Dijk et al., “Effects of transcutaneous electrical nerve stimulation (TENS) on non-pain related cognitive and behavioural functioning”, Rev Neurosci., 13:257-270 (2002).
Wakeling et al., Muscle activity damps the soft tissue resonance that occurs in response to pulsed and continuous vibrations, J Appl Physiol, May 17, 2002, vol. 93, pp. 1093-1103.
Waters et al., “Functional Electrical Stimulation of the Peroneal Nerve for Hemiplegia”, The Journal of Bone and Joint Surgery, 67:792-793 (1985).
Witteveen et al., Vibro- and Electrotactile User Feedback on Hand Opening for Myoelectric Forearm Prostheses, IEEE Transactions on Biomedical Engineering, Aug. 2012, vol. 59, Issue No. 8, pp. 2219-2226.
Related Publications (1)
Number Date Country
20210322261 A1 Oct 2021 US
Provisional Applications (1)
Number Date Country
62836195 Apr 2019 US
Continuations (1)
Number Date Country
Parent 16853477 Apr 2020 US
Child 17305268 US